You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma

Article Text

Article menu

This article has a correction. Please see:

Download PDFPDF

Erratum
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
  1. Mira A. Patel1,
  2. Jennifer E. Kim1,
  3. Debebe Theodros1,
  4. Ada Tam2,
  5. Esteban Velarde3,
  6. Christina M. Kochel2,
  7. Brian Francica2,
  8. Thomas R. Nirschl2,
  9. Ali Ghasemzadeh2,
  10. Dimitrios Mathios4,
  11. Sarah Harris-Bookman4,
  12. Christopher C. Jackson4,
  13. Christina Jackson4,
  14. Xiaobu Ye4,
  15. Phuoc T. Tran2,3,6,
  16. Betty Tyler4,
  17. Vladimir Coric5,
  18. Mark Selby5,
  19. Henry Brem1,4,
  20. Charles G. Drake6,
  21. Drew M. Pardoll2 and
  22. Michael Lim1,4,v
  1. Aff1 grid.21107.350000000121719311The Johns Hopkins University School of Medicine Baltimore USA
  2. Aff2 Department of Oncology Baltimore USA
  3. Aff3 Department Radiation Oncology Baltimore USA
  4. Aff4 grid.21107.350000000121719311Department of NeurosurgeryThe Johns Hopkins University School of Medicine 600 N. Wolfe St. Phipps Building Rm 123 21287 Baltimore MD USA
  5. Aff5 grid.419971.3Bristol-Myers Squibb Company San Francisco CA USA
  6. Aff6 The Brady Urological Institute Baltimore USA
  1. ↵v mlim3{at}jhmi.edu

  • The online version of the original article can be found under doi:10.1186/s40425-016-0132-2.

https://doi.org/10.1186/s40425-016-0181-6

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Erratum

    Unfortunately, after publication of this article [1], it was noticed that a funding source was not mentioned. Bristol-Myers Squibb was intended to be included in the ‘Financial Support’ section of the article.

    Reference

    1. 1.↵
      2. Patel MA ,
      3. Kim JE ,
      4. Theodros D ,
      5. Tam A ,
      6. Velarde E ,
      7. Kochel CM ,
      8. Francica B ,
      9. Nirschl TR ,
      10. Ghasemzadeh A ,
      11. Mathios D ,
      12. Harris-Bookman S ,
      13. Jackson CC ,
      14. Jackson C ,
      15. Ye X ,
      16. Tran PT ,
      17. Tyler B ,
      18. Coric V ,
      19. Selby M ,
      20. Brem H ,
      21. Drake CG ,
      22. Pardoll DM ,
      23. Lim M
      . Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma. J Immunothera Cancer. 2016;4:28 doi:10.1186/s40425-016-0132-2
      OpenUrl